青黄散加解毒化瘀方治疗骨髓增生异常综合征疗效及对患者血清可溶性细胞间黏附分子-1、转化生长因子-β_(1)的影响

Qinghuang powder and Jiedu Huayu recipe in the treatment of myelodysplastic syndromeand its effect on serum soluble intercellular adhesion molecule-1 and transforming growth factor-β_(1) levels

目的:探究青黄散加解毒化瘀方对毒瘀阻滞证骨髓增生异常综合征(MDS)的疗效及血清可溶性细胞间黏附分子(sICAM-1)、转化生长因子β_(1)(TGF-β_(1))水平的影响。方法:选取76例MDS患者作为研究对象,随机分为试验组和对照组,各38例,对照组予以西医基础治疗,试验组在对照组基础上联合青黄散加解毒化瘀方治疗。两组患者均于给药4个月后评估临床疗效、中医证候积分、血常规指标水平、血清学免疫因子水平,并记录两组患者不良反应发生率。结果:治疗后两组患者的主症及次症评分均低于治疗前,且试验组均低于对照组(P<0.05)。试验组临床疗效优于对照组(P<0.05)。两组不良反应发生率比较差异无统计学意义(P>0.05)。治疗后,两组患者的血清sICAM-1水平均低于治疗前,且试验组低于对照组(P<0.05);两组治疗后TGF-β_(1)水平较治疗前升高,试验组高于对照组(P<0.05)。治疗后,两组PLT、Hb、WBC水平较治疗前升高,试验组PLT、Hb水平均高于对照组(P<0.05)。结论:青黄散加解毒化瘀方应用于毒瘀阻滞证MDS患者治疗中,有助于促进患者症状恢复,改善血常规指标水平,调节血清免疫因子水平,且安全性良好。

Objective:To explore the curative effect of Qinghuang powder plus Jiedu Huayu recipe on myelodysplastic syndrome(MDS)and the level of serum soluble intercellular adhesion molecule(sICAM-1)and transforming growth factorβ_(1)(TGF-β_(1))influence.Methods:76 patients with MDS were selected as the research objects.They were randomly divided into experimental group and control group,with 38 cases in each group.The control group was treated with basic western medicine,and the experimental group was treated with Qinghuang powder and Jiedu Huayu formula on the basis of the control group.The clinical efficacy,TCM syndrome score,hemogram index level and serological immune factor level of the two groups were evaluated 4 months after administration,and the incidence of adverse reactions was recorded.Results:After administration,the two group’s scores of secondary and main syndromes were lower than those before treatment,the scores of the control group were higher than the experimental group(P<0.05).The clinical effect of the experimental group was better than that of the control group(P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).After treatment,the level of serum sICAM-1 in the two groups was lower than that before treatment,and that in the control group was higher than the experimental group(P<0.05).TGF-β_(1) in the experimental group was higher than that in the control group(P<0.05).After treatment,the levels of PLT,Hb and WBC in the two groups were higher than those before treatment,and the levels of PLT and Hb in the experimental group were higher than those in the control group(P<0.05).Conclusion:Qinghuang powder plus Jiedu Huayu recipe is used in the treatment of patients with MDS with stagnation of toxins and stasis syndrome,which helps to promote the recovery of symptoms,improve the level of blood indicators,and regulate the level of serum immune factors.It has superior clinical efficacy and good safety.